Publication | Closed Access

The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis

ObesityMetabolic SyndromeInflammationHepatologyLiver PhysiologyHepatic Fibrosis RiskHepatology InflammationHepatotoxicityLiver DiseaseHepatology FibrosisDermatologyFatty Liver DiseaseMedicineDrug-induced Liver InjuryHealth Sciences